欢迎登录材料期刊网

材料期刊网

高级检索

药物引起的肝损伤是全世界关注的健康问题,药源性肝损伤的早期诊断仍然是临床治疗肝损伤的一大难题。本研究中,首先利用对乙酰氨基酚、四氯化碳、大黄素、雷公藤甲素和马兜铃酸构建不同类型的肝细胞损伤模型,利用超高效液相色谱-质谱联用技术( UPLC-MS)分别得到正常组和损伤组的细胞代谢轮廓谱。然后利用模式识别构建分类模型,筛选肝损伤相关的差异代谢物。结果显示,不同类型肝损伤在肝细胞代谢谱上可以被区分开,最终鉴定出14种差异代谢物。损伤组肝细胞经保肝阳性药联苯双酯干预后,差异代谢物水平均趋向于正常组,在一定程度上验证了差异标志物与肝损伤的相关性。实验结果表明细胞代谢组学是研究药物肝损伤的有效工具之一。

Drug-induced hepatotoxicity is a worldwide health issue. And diagnosing the injury in the early stage is still a challenge in clinic. In this study,pattern recognition analysis of the ultra high performance liquid chromatography-mass spectrometry( UPLC-MS)of hepatocytes HL7702 was performed to develop differential metabolites related to hepatotoxicity induced by hepatotoxicants,including carbon tetrachloride(CCl4),acetaminophen(APAP),emodin, aristolochic acid( AA)and triptolide. Hepatocytes injuries were induced by 48 h of treatment with CCl4(4 mmol/L),APAP(6. 5 mmol/L),emodin(14 μmol/L),AA(35 μmol/L)and trip-tolide(18 nmol/L),separately. Global metabolomics profiling,multivariate analysis and data-base searching were performed to discover common differential metabolites for live injury. The positive hepatoprotective drug,bifendate,was used to repair triptolide induced hepatocytes in-jury,and bifendate-induced changes of hepatotoxicity-related metabolites were investigated. In the results,fatty acid oxidation and cellular oxidative stress-related metabolites,including nico-tinamide adenine dinucleotide and glutathione were significantly changed between the control and hepatotoxicant-treated groups,and after treatment with bifendate,those perturbed metab-olites all partly returned to normal level. In conclusion,we discovered potential hepatotoxicity-related metabolites that could be used to evaluate hepatotoxicity induced by chemicals,drugs and traditional Chinese medicines. This study also proved that metabolomics is one of the effec-tive tools to investigate drug-induced hepatotoxicity.

参考文献

[1] Beger RD;Sun J;Schnackenberg LK.Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.[J].Toxicology and Applied Pharmacology,20102(2):154-166.
[2] Fung M.[J].DRUG INFORMATION JOURNAL,200135(1):293.
[3] 徐鑫;屈彩芹.药物性肝损伤机制[J].医学综述,2008(5):747-749.
[4] 余欣尉;吴谦;吕望;王彦;马小琼;陈喆;阎超.基于液相色谱-质谱联用技术的肺癌细胞代谢组学分析[J].色谱,2013(7):691-696.
[5] 李艳杰;张春兰;张晗;赵欣捷;侯丽辉;许国旺.基于超高效液相色谱-质谱分析的代谢组学在小檗碱治疗多囊卵巢综合征研究中的应用[J].色谱,2014(5):464-471.
[6] 史栋栋;况媛媛;王桂明;彭章晓;王彦;阎超.细胞代谢组学用于羽扇豆醇干预人乳腺癌细胞 MCF-7的机理探究[J].色谱,2014(3):278-283.
[7] 彭思远;严丽娟;张洁;申河清.利用代谢组学技术研究全氟辛酸的人肝脏毒性机制[J].色谱,2012(2):123-127.
[8] Kim K B;Chung M W;Um S Y.[J].METABOLOMICS,20084(4):377.
[9] Yang L;He Y;Wang C;Li W;Hu Z.Bile Acids Metabonomic Study on the CCl(4)- and alpha-Naphthylisothiocyanate-Induced Animal Models: Quantitative Analysis of 22 Bile Acids by Ultraperformance Liquid Chromatography-Mass Spectrometry.[J].Chemical research in toxicology,200812(12):2280-2288.
[10] Yamazaki,M.;Miyake,M.;Sato,H.;Masutomi,N.;Tsutsui,N.;Adam,K.-P.;Alexander,D.C.;Lawton,K.A.;Milburn,M.V.;Ryals,J.A.;Wulff,J.E.;Guo,L..Perturbation of bile acid homeostasis is an early pathogenesis event of drug induced liver injury in rats[J].Toxicology and Applied Pharmacology,20131(1):79-89.
[11] Li,X.;Zhang,F.;Wang,D.;Li,Z.;Qin,X.;Du,G..NMR-based metabonomic and quantitative real-time PCR in the profiling of metabolic changes in carbon tetrachloride-induced rat liver injury[J].Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis,2014:42-49.
[12] Kim J W;Ryu S H;Kim S.[J].Analytical Chemistry,201385(23):11326.
[13] Wang L;Yao D;Chen C.[J].FASEB JOURNAL,2013:27.
[14] Xiong,Y.-H.;Xu,Y.;Yang,L.;Wang,Z.-T..Gas chromatography-mass spectrometry-based profiling of serum fatty acids in acetaminophen-induced liver injured rats[J].Journal of applied toxicology,20141/2(1/2):149-157.
[15] Shaw D.Toxicological risks of Chinese herbs.[J].Planta medica: Natural products and medicinal plant research,201017(17):2012-2018.
[16] Huang,T.-C.;Chen,S.-M.;Li,Y.-C.;Lee,J.-A..Urinary d-lactate levels reflect renal function in aristolochic acid-induced nephropathy in mice[J].Biomedical Chromatography: An International Journal Devoted to Research in Chromatographic Methodologies and Their Applications in the Biosciences,20139(9):1100-1106.
[17] Dettmer K;Nuernberger N;Kaspar H.[J].Analytical Biochemistry,2011399(3):1127.
[18] Tautenhahn R;Patti G J;Rinehart D.[J].Analytical Chemistry,201284(11):5035.
[19] Chen J;Zhao X;Fritsche J.[J].Analytical Chemistry,200880(4):1280.
[20] Shen, G.;Chen, Y.;Sun, J.;Zhang, R.;Zhang, Y.;He, J.;Tian, Y.;Song, Y.;Chen, X.;Abliz, Z..Time-course changes in potential biomarkers detected using a metabonomic approach in Walker 256 tumor-bearing rats[J].Journal of proteome research,20114(4):1953-1961.
[21] Chan, E.C.Y.;Pasikanti, K.K.;Nicholson, J.K..Global urinary metabolic profiling procedures using gas chromatography-mass spectrometry[J].Nature protocols erecipes for researchers,201110(10):1483-1499.
[22] Peng,S.;Yan,L.;Zhang,J.;Wang,Z.;Tian,M.;Shen,H..An integrated metabonomics and transcriptomics approach to understanding metabolic pathway disturbance induced by perfluorooctanoic acid[J].Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis,2013:56-64.
[23] Sakagami H;Sugimoto M;Tanaka S.[J].METABOLOMICS,201410(2):270.
[24] Amet Y;Zerilli A;Goasduff T.[J].Biochemical Pharmacology,199754(8):947.
[25] Matsunaga I;Sumimoto T;Ueda A;Kusunose E;Ichihara K.Fatty acid-specific, regiospecific, and stereospecific hydroxylation by cytochrome P450 (CYP152B1) from Sphingomonas paucimobilis: substrate structure required for alpha-hydroxylation.[J].Lipids,20004(4):365-371.
[26] Amet Y F;Adas A A.[J].Alcohol Clinical Experimental Reseach,199822(7):1493.
[27] Ana Carla B B;Fabricio B;Livia B.[J].ACTA PHARMACOLOGICA SINICA,200930(1):90.
[28] Liu,T.F.;Vachharajani,V.T.;Yoza,B.K.;McCall,C.E..NAD+ -dependent sirtuin 1 and 6 proteins coordinate a switch from glucose to fatty acid oxidation during the acute inflammatory response[J].The Journal of biological chemistry,201231(31):25758-25769.
[29] Diaz Ochoa J G;Bucher J;Pery A R R.[J].Front Phar-macol,20123:204.
[30] Pan SY;Yang R;Dong H;Yu ZL;Ko KM.Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice.[J].European Journal of Pharmacology: An International Journal,20061/3(1/3):170-175.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%